Brief: Bioscrip Quarterly Loss Per Share $0.14

Option Care Health

15/03/2019 11:10

March 15 (Reuters) - BioScrip Inc  BIOS.O :
    * BIOSCRIP REPORTS FOURTH QUARTER AND FULL YEAR 2018
FINANCIAL
RESULTS
    * Q4 REVENUE $183.6 MILLION VERSUS REFINITIV IBES ESTIMATE
OF
$188.4 MILLION
    * SAYS PENDING COMBINATION ANNOUNCED WITH OPTION CARE,
COMPANY
WILL NOT BE PROVIDING UPDATED 2019 BIOSCRIP FINANCIAL GUIDANCE
    * QUARTERLY LOSS PER SHARE $0.14
    * Q4 EARNINGS PER SHARE VIEW $-0.03 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX4K3KL0 
Further company coverage:  BIOS.O 

 ((Reuters.Briefs@thomsonreuters.com;))